SenzaGen Agrees to Acquire Alcyomics for About SEK 28M
The cash deal includes up to about SEK 25M in earn-outs and is partly funded by a SEK 25M convertible to Eiffel. It is expected to close around 4 November 2026. Alcyomics reported FY25/26 revenue of about SEK 19.5M and an EBITDA margin of about 24%.
SenzaGen agreed to acquire UK-based Alcyomics for ~SEK 28M cash, with up to ~SEK 25M in earn-outs, funded partly by a SEK 25M convertible to Eiffel. Deal expected around 4 Nov 2026; Alcyomics FY25/26 revenue ~SEK 19.5M with ~24% EBITDA margin.Material DetailsContext by AI AnalystThis is a mid-cycle…